Find us on:

Research

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis

Title
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis
Publication Type
Journal Article
Research Type
Human
Reported as
Case Report/Series/Restrospective Study
Date
August 12, 2015
Authors
Roginsky G, Alexoff A, Ehrenpreis ED.
Institution
NorthShore University HealthSystem Evanston, Skokie; Loyola University Chicago
Link
Abstract

Three patients with symptomatic mesenteric panniculitis were treated with 4.5mg of LDN nightly for 12 weeks. LDN was safe and well tolerated. Two of the three patients experienced symptomatic improvement.